$MCRB·4

Seres Therapeutics, Inc. · Jan 27, 5:51 PM ET

Seres Therapeutics, Inc. 4

4 · Seres Therapeutics, Inc. · Filed Jan 27, 2017

Insider Transaction Report

Form 4
Period: 2017-01-26
Trucksis Michele
Chief Medical Officer and EVP
Transactions
  • Award

    Stock Option (right to buy)

    2017-01-26+100,000100,000 total
    Exercise: $9.89Exp: 2027-01-25Common Stock (100,000 underlying)
  • Award

    Restricted Stock Units

    2017-01-26+37,50037,500 total
    Common Stock (37,500 underlying)
Footnotes (3)
  • [F1]The option will vest as to 25% of the shares on January 26, 2018. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F3]These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020.

Documents

2 files